| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
6(IV) Chain of Collagen Type IV in Alport Syndrome Is Related to a Failure at the Protein Assembly Level and Does Not Result in Diffuse Leiomyomatosis


From the Division of Pathology,*
Hospital for Sick
Children and University of Toronto, Toronto, Canada; the Divisions of
Immunology
and Ultrastructural
Biology,
Shigei Medical Research Institute,
Okayama, Japan; the Department of Molecular Biology and
Biochemistry,§
Okayama University Medical
School, Okayama, Japan; and the Department of
Pathobiology,¶
Ontario Veterinary
College and University of Guelph, Guelph, Canada
X-linked Alport syndrome is a progressive nephropathy associated
with mutations in the COL4A5 gene. The kidney usually lacks the
3-
6 chains of collagen type IV, although each is coded by
a separate gene. The molecular basis for this loss remains unclear. In
canine X-linked hereditary nephritis, a model for X-linked
Alport syndrome, a COL4A5 mutation results in reduced mRNA
levels for the
3,
4, and
5 chains in the
kidney, implying a mechanism coordinating the production of
these 3 chains. To examine whether production of
6 chain is under
the same control, we studied smooth muscle cells from this
animal model. We determined the canine COL4A5 and COL4A6 genes are
separated by 435 bp, with two first exons for COL4A6 separated
by 978 bp. These two regions are
78% identical to the human
sequences that have promoter activity. Despite this potential basis for
coordinated transcription of the COL4A5 and COL4A6 genes, the
6 mRNA level remained normal in affected male dog smooth muscle
while the
5 mRNA level was markedly reduced. However, both
5 and
6 chains were absent at the protein level. Our results
suggest that production of the
6 chain is under a control mechanism
separate from that coordinating the
3-
5 chains and that the lack
of the
6 chain in Alport syndrome is related to a failure at the
protein assembly level, raising the possibility that the
5
and
6 chains are present in the same network. The lack of the
6
chain does not obviously result in disease, in particular
leiomyomatosis, as is seen in Alport patients with deletions
involving the COL4A5 and COL4A6 genes.
This article has been cited by other articles:
![]() |
S. J. Harvey, J. Perry, K. Zheng, D. Chen, Y. Sado, B. Jefferson, Y. Ninomiya, R. Jacobs, B. G. Hudson, and P. S. Thorner Sequential Expression of Type IV Collagen Networks: Testis as a Model and Relevance to Spermatogenesis Am. J. Pathol., May 1, 2006; 168(5): 1587 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Harvey, K. Zheng, B. Jefferson, P. Moak, Y. Sado, I. Naito, Y. Ninomiya, R. Jacobs, and P. S. Thorner Transfer of the {alpha}5(IV) Collagen Chain Gene to Smooth Muscle Restores in Vivo Expression of the {alpha}6(IV) Collagen Chain in a Canine Model of Alport Syndrome Am. J. Pathol., March 1, 2003; 162(3): 873 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Miner Alport Syndrome with Diffuse Leiomyomatosis : When and When Not? Am. J. Pathol., June 1, 1999; 154(6): 1633 - 1635. [Full Text] [PDF] |
||||
![]() |
D.-B. Borza, O. Bondar, Y. Ninomiya, Y. Sado, I. Naito, P. Todd, and B. G. Hudson The NC1 Domain of Collagen IV Encodes a Novel Network Composed of the alpha 1, alpha 2, alpha 5, and alpha 6 Chains in Smooth Muscle Basement Membranes J. Biol. Chem., July 20, 2001; 276(30): 28532 - 28540. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |